Retraction notice to "Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis."

Journal

Kidney international reports
ISSN: 2468-0249
Titre abrégé: Kidney Int Rep
Pays: United States
ID NLM: 101684752

Informations de publication

Date de publication:
Mar 2022
Historique:
entrez: 8 3 2022
pubmed: 9 3 2022
medline: 9 3 2022
Statut: epublish

Résumé

[This retracts the article DOI: 10.1016/j.ekir.2020.12.018.].

Identifiants

DOI: 10.1016/j.ekir.2022.01.1069 PMID: 35257087 PMC: PMC8897481
pubmed: 35257087
doi: 10.1016/j.ekir.2022.01.1069
pii: S2468-0249(22)01131-7
pmc: PMC8897481
doi:

Types de publication

Retraction of Publication

Langues

eng

Pagination

665

Commentaires et corrections

Type : RetractionOf

Informations de copyright

© 2022 International Society of Nephrology. Published by Elsevier Inc.

Auteurs

Robert Provenzano (R)

School of Medicine, Wayne State University, Detroit, Michigan, USA.

Steven Fishbane (S)

Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA.

Lynda Szczech (L)

FibroGen, Inc., San Francisco, California, USA.

Robert Leong (R)

FibroGen, Inc., San Francisco, California, USA.

Khalil G Saikali (KG)

FibroGen, Inc., San Francisco, California, USA.

Ming Zhong (M)

FibroGen, Inc., San Francisco, California, USA.

Tyson T Lee (TT)

FibroGen, Inc., San Francisco, California, USA.

Mark T Houser (MT)

AstraZeneca, Gaithersburg, Maryland, USA.

Lars Frison (L)

AstraZeneca, Mölndal, Sweden.

John Houghton (J)

AstraZeneca, Gaithersburg, Maryland, USA.

Dustin J Little (DJ)

AstraZeneca, Gaithersburg, Maryland, USA.

Kin-Hung Peony Yu (KH)

FibroGen, Inc., San Francisco, California, USA.

Thomas B Neff (TB)

FibroGen, Inc., San Francisco, California, USA.

Classifications MeSH